Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

315

HTML

1250

Figures (1-2)

180

Tables (1-3)

124

Sum=1869

Feb 14, 2007 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 14, 2007; 13(6): 950-954
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.950

Figure 1 Representative results from methylation-specific PCR analysis performed in stool samples from patients with colorectal cancer.

Figure 2 Sequence comparison between amplicons of methylated SFRP2 and wild-type SFRP2.

Citation: Huang ZH, Li LH, Yang F, Wang JF. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 2007; 13(6): 950-954
URL: https://www.wjgnet.com/1007-9327/full/v13/i6/950.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i6.950